Search
  • mmahomed2
    • Feb 1, 2018
    • 1 min read

Seed investment from The House Fund

Valitor is proud to announce that we have received a seed investment from The House Fund. These funds will augment our current SBIR funding by accelerating the commercialization of our lead therapeutic product for indications in ophthalmology. 

26 views0 comments

Recent Posts

See All

Series A financing

Valitor is proud to announce the final close of our Series A financing, co-lead by the Berkeley Catalyst Fund and ShangPharma Innovations. This round oversubscribed our initial offering, and we raised

2550

© Valitor, Inc 2021

  • LinkedIn - White Circle